← Back to Clinical Trials
Recruiting NCT07061067
NCT07061067 Affection of Symptoms Duration on Outcomes of Lumbar Spine Surgery
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT07061067 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kafrelsheikh University |
| Condition | Symptom Duration |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-07-19 |
| Primary Completion | 2026-01-01 |
Trial Parameters
Condition Symptom Duration
Sponsor Kafrelsheikh University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-07-19
Completion 2026-01-01
All Conditions
Interventions
Lumbar Spine Surgery
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study aims to evaluate the affection of symptoms duration on outcomes of lumbar spine surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years old. * Both sexes. * Patients undergoing lumbar spine surgery * Presenting symptoms include lumbar back pain, lumbar radiculopathy, neurogenic claudication, lower-extremity weakness, bowel or bladder symptoms, and duration of symptoms. Exclusion Criteria: * Previous spinal surgery. * Vascular claudication. * Comorbid pathology affecting walking ability. * Severe comorbidities that may impact surgery outcomes (e.g., uncontrolled diabetes, cardiovascular disease). * Bony metastases. * Unfit for general anaesthesia.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology